Coenzyme Q10 combined with mild hypothermia after cardiac arrest: A preliminary study

Circulation

Volumn 110, Issue 19, 2004, Pages 3011-3016

  Damian, Maxwell Simon ^a,c   Ellenberg, Diana ^b   Gildemeister, Ramona ^b   Lauermann, Jörg ^b   Simonis, Gregor ^b   Sauter, Wolfgang ^b   Georgi, Christian ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Brain; Free radicals; Heart arrest; Metabolism

Indexed keywords

ADRENALIN; PLACEBO; PROTEIN S 100; SANOMIT; UBIDECARENONE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORE TEMPERATURE; DEGENERATIVE DISEASE; DRUG SOLUTION; FEMALE; GLASGOW OUTCOME SCALE; HEART ARREST; HUMAN; HYPOTHERMIA; HYPOXIA; MALE; MORBIDITY; NASOGASTRIC TUBE; NEUROPROTECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN DAMAGE, CHRONIC; COMBINED MODALITY THERAPY; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; GLASGOW OUTCOME SCALE; HEART ARREST; HUMANS; HYPOTHERMIA, INDUCED; LIFE TABLES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; S100 PROTEINS; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UBIQUINONE;

EID: 8544253235     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000146894.45533.C2     Document Type: Article

References (31)

1. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, et al. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol. 1997;30:1500-1505.
2. Safar P. Cerebral resuscitation after cardiac arrest: research initiatives and future directions. Ann Emerg Med. 1993;22:324-349.
3. Denton R, Thomas AN. Cardiopulmonary resuscitation: a retrospective review. Anaesthesia. 1997;52:324-327.
4. Maiese K. Sequelae of cardiac arrest. MedLink Neurology. 2002.
5. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557-563.
6. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-556.
7. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol. 1997;41:160-165.
8. Matthews RT, Yang L, Browne S, et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998;95:8892-8897.
9. 10 and remacemide in Huntington's disease. Neurology. 2001; 57:397-404.
10. Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59:1541-1550.
11. Rosenfeldt FL, Pepe S, Linnane A, et al. Coenzyme Q10 protects the aging heart against stress: studies in rats, human tissues, and patients. Ann N Y Acad Sci. 2002;959:355-359.
12. Rogove HJ, Safar P, Sutton-Tyrrell K, Abramson NS. Old age does not negate good cerebral outcome after cardiopulmonary resuscitation: analyses from the brain resuscitation clinical trials: the Brain Resuscitation Clinical Trial I and II Study Groups. Crit Care Med. 1995;23:18-25.
13. Leonov T, Sterz F, Safar P, et al. Mild cerebral hypothermia during and after cardiac arrest improves neurologic outcome in dogs. J Cereb Blood Flow Metab. 1990;10:57-70.
14. Weinrauch V, Safar P, Tisherman S, et al. Beneficial effect of mild hypothermia and detrimental effect of deep hypothermia after cardiac arrest in dogs. Stroke. 1992;23:1454-1462.
15. Kuboyama K, Safar P, Radovsky A, et al. Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study. Crit Care Med. 1993; 21:1348-1358.
16. Yanagawa Y, Ishihara S, Norio H, et al. Preliminary clinical outcome study of mild resuscitative hypothermia after out-of-hospital cardiopulmonary arrest. Resuscitation. 1998;39:61-66.
17. Jastremski M, Sutton-Tyrrell K, Vaagenes P, et al. Glucocorticoid treatment does not improve neurological recovery following cardiac arrest: Brain Resuscitation Clinical Trial I Study Group. JAMA. 1989; 262:3427-3430.
18. Roine RO, Kaste M, Kinnunen A, et al. Nimodipine after resuscitation from out-of-hospital ventricular fibrillation: a placebo-controlled, double-blind, randomized trial. JAMA. 1990;264:3171-3177.
19. Brain Resuscitation Clinical Trial II Study Group. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Engl J Med. 1991;324:1225-1231.
20. Schroder R (FLUNA Study Group Berlin). Flunarizine iv after cardiac arrest (Fluna-study): study design and organisational aspects of a double-blind, placebo-controlled randomized study. Resuscitation. 1989;17:S121-S127.
21. Monsalve F, Rucabado L, Ruano M, et al. The neurologic effects of thiopental therapy after cardiac arrest. Intensive Care Med. 1987;13:244-248.
22. Aldrete JA, Romo-Salas F, Mazzia VD, Tan SL. Phenytoin for brain resuscitation after cardiac arrest: an uncontrolled clinical trial. Crit Care Med. 1981;9:474-477.
23. Maiese K, Vincent A, Lin SH, et al. Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection. J Neurosci Res. 2000;62:257-272.
24. Beal MF. Oxidative metabolism. Ann N Y Acad Sci. 2000;924:164-169.
25. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-1312.
26. Beal MF. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 2000;23:298-304.
27. Shibata M, Hattori H, Sasaki T, et al. Subcellular localization of a promoter and an inhibitor of apoptosis (Smac/DIABLO and XIAP) during brain ischemia/reperfusion. Neuroreport. 2002;13:1985-1988.
28. Lodi R, Hart PE, Rajagopalan B, et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol. 2001;49:590-596.
29. Beal MF, Henshaw DR, Jenkins BG, et al. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol. 1994;36:882-888.
30. Murphy MP. Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction. Expert Opin Biol Ther. 2001;1:133-140.
31. Schulz JB, Weller M, Matthews RT, et al. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Diff. 1998;5:847-857.